News
Avalyn Pharma has added on $100 million to accelerate novel inhaled versions of approved drugs for lung conditions. The company’s series D fundraise was led by Suvretta Capital Management and SR One ...
Avalyn Pharma has drawn in another fundraising round, this time a $100 million oversubscribed series D to continue developing ...
Hailey Bieber's Rhode just launched the Glazing Mist, a superfine spray meant to deliver instant skin-plumping hydration. Here's an honest review.
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for children.
GSK (GSK) faces an investigation from U.S. Senator Maggie Hassan over its decision to discontinue Flovent HFA asthma inhaler last year. Read more here.
U.S. Senator Maggie Hassan (D-NH) is intensifying her scrutiny of GSK Plc (NYSE:GSK) over the company's decision to pull its widely used asthma inhaler, Flovent HFA, from the market. One year ...
HPE's must divest its Instant On business and Juniper will have to license its Mist AI software.
Senator Maggie Hassan is investigating GSK's discontinuation of Flovent HFA, citing increased hospitalizations, higher drug costs, and lost Medicaid rebates.
Meanwhile, the company highlighted growth in its branded products, with Primatene MIST sales rising 20% year-over-year, attributed to increased unit volumes and expanded physician outreach.
The researchers found that female permanent night shift workers had higher covariate-adjusted odds of moderate-to-severe asthma compared to female day workers (odds ratio, 1.50), but no ...
Cambridge-based start-up rolls out industry-first inhaler for delivering large amounts of drug in a single inhalation, enabling next-gen inhaled biologics for novel therapiesCAMBRIDGE, 24 June 2025: ...
These are the best humidifiers you can buy in every category, from Dyson AM10 and Levoit LV600HH to HoMedics TotalComfort Deluxe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results